---
$id: https://graph.org.ai/products/commodity/51372005
$type: Product
source: UNSPSC
code: "51372005"
title: "Cyprenorphine"
class: "51372000"
classTitle: "Controlled substance analgesic morphinans"
family: "51370000"
familyTitle: "Controlled substance analgesics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cyprenorphine

**UNSPSC Code**: 51372005
**Class**: [Controlled substance analgesic morphinans](Controlled substance analgesic morphinans.mdx)
**Family**: [Controlled substance analgesics](../Controlled substance analgesics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an opioid receptor agonist with the molecular formula C26H33NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1P6HEG5ZHS, chemically known as 6,14-ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-4,5-epoxy-3-hydroxy-6-methoxy-alpha,alpha-dimethyl-, (5alpha,7alpha)- but generally known as cyprenorphine, which bears US NIH Compound Identifier 20435. European Medicines Agency schedules Cyprenorphine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06873MIG. The term CYPRENORPHINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). Most nations schedule cyprenorphine under HS 29391900 and SITC 54141. As of Q4 2014, CYPRENORPHINE remains the US FDA Preferred Term for this commodity. Cyprenorphine bears US NLM identifiers UMLS ID C0056851 and NCI Concept Code C87355. SMILES: O1C2C34C5(C(N(CC3)CC3CC3)CC3C4C1C(O)CC3)CC(C2(OC)C=C5)C(O)(C)C.

